Your browser doesn't support javascript.
loading
Inhibition of DPAGT1 suppresses HER2 shedding and trastuzumab resistance in human breast cancer.
Yang, Muwen; Li, Yue; Kong, Lingzhi; Huang, Shumei; He, Lixin; Liu, Pian; Mo, Shuang; Lu, Xiuqing; Lin, Xi; Xiao, Yunyun; Shi, Dongni; Huang, Xinjian; Chen, Boyu; Chen, Xiangfu; Ouyang, Ying; Li, Jun; Lin, Chuyong; Song, Libing.
Affiliation
  • Yang M; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine and.
  • Li Y; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine and.
  • Kong L; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine and.
  • Huang S; Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong China.
  • He L; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine and.
  • Liu P; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Mo S; Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong China.
  • Lu X; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine and.
  • Lin X; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine and.
  • Xiao Y; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine and.
  • Shi D; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine and.
  • Huang X; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine and.
  • Chen B; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine and.
  • Chen X; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine and.
  • Ouyang Y; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine and.
  • Li J; Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong China.
  • Lin C; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine and.
  • Song L; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine and.
J Clin Invest ; 133(14)2023 07 17.
Article in En | MEDLINE | ID: mdl-37463446
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: J Clin Invest Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: J Clin Invest Year: 2023 Type: Article